T1	Participants 561 611	23 patients treated with gentamicin-cefoxitin (G-C
T3	Participants 765 816	14 patients treated with netilmicin-cefoxitin (N-C)
T2	Participants 327 429	Thirty-seven surgical patients were evaluated for efficacy and 46 patients were evaluated for toxicity
